Biota Pharmaceuticals, Inc. (BOTA) has 9 open-market insider trades by 5 insiders since 2014. The most active filer is Joseph M. Patti, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| James Fox | Dir | — | 2 | $281K | 2015-08-11 |
| Russell H. Plumb | Chairman | — | 1 | $96K | 2015-09-16 |
| Joseph M. Patti | CEO | — | 4 | $90K | 2015-09-25 |
| Anne Vanlent | Dir | — | 1 | $77K | 2015-06-22 |
| Mark P. Colonnese | CFO | — | 1 | $10K | 2016-02-09 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark P. Colonnese | CFO | Buy | $10K | 2016-02-09 |
| Joseph M. Patti | CEO | Buy | $9K | 2015-09-25 |
| Anne Vanlent | Director | Buy | $77K | 2015-06-22 |
| James Fox | Director | Buy | $142K | 2015-06-10 |
| James Fox | Director | Buy | $139K | 2015-06-09 |
| Joseph M. Patti | EVP & Corporate Dev & Strategy | Buy | $29K | 2014-06-30 |
Companies that share insiders with BOTA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Joseph M. Patti | EVP & Corporate Dev & Strategy | Buy | $14K | 2014-06-27 |
| Joseph M. Patti | EVP & Corporate Dev & Strategy | Buy | $38K | 2014-06-10 |
| Russell H. Plumb | President | Buy | $96K | 2014-06-10 |